Lovaza and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Lovaza (omega-3-acid ethyl esters), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Advair Hfa, and have Narcolepsy.

The phase IV clinical study analyzes which people have Otitis when taking Lovaza. It is created by eHealthMe based on reports of 16,646 people who have side effects when taking Lovaza from the FDA, and is updated regularly.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 17,340 Lovaza users. Check the latest studies of Lovaza.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,407 drugs and 1,842 conditions by eHealthMe. Check the latest studies of Otitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

16,646 people reported to have side effects when taking Lovaza.
Among them, 29 people (0.17%) have Otitis.

Among these 29 people:

How long have people been on Lovaza when they have Otitis? *

What is the gender of people who have Otitis when taking Lovaza? *

female: 89.29 %
male: 10.71 %

What is the age of people who have Otitis when taking Lovaza? *

What are other drugs people take besides Lovaza? *

What are other side effects people have besides Otitis? *

Sinusitis (inflammation of sinus): 8 people, 27.59%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 24.14%
Pneumonia: 6 people, 20.69%
Pain: 6 people, 20.69%
Infection: 6 people, 20.69%
Urinary Tract Infection: 5 people, 17.24%
Nausea And Vomiting: 5 people, 17.24%
Dizziness: 5 people, 17.24%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 17.24%
Headache (pain in head): 4 people, 13.79%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 24.14%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 24.14%
Diabetes: 6 people, 20.69%
High Blood Pressure: 4 people, 13.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 13.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.34%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.34%
Pain: 3 people, 10.34%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 10.34%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Lovaza and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lovaza:

Lovaza (17,340 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,407 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,842 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omega-3-acid ethyl esters (the active ingredients of Lovaza) and Lovaza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.